The objective of this study was to investigate the predictors and prognostic significance of post-procedural cardiac troponin (cTn)-I elevations in a consecutive series of patients who underwent elective percutaneous coronary intervention (PCI). cTn-I was measured in 100 patients immediately before and within 24 h after the elective PCI. Post-procedural cTn-I elevation was observed in 27 of the 100 patients. In multivariate analysis, basal haemoglobin values and the number of repeated balloon dilatations were found to be independent predictors of cTn-I elevation. During the follow-up period of 12 ± 1.2 months, the cTn-I-positive group had more major adverse cardiovascular events than the cTn-I-negative group (33.3% versus 16.4%, respectively), but the difference was not significant. An increase in cTn-I levels following elective PCI procedures was frequent but did not predict a poor long-term outcome.
HurstJW: The first coronary angioplasty as described by Andreas Gruentzig. Am J Cardiol1986; 57: 185–186.
2.
PuelJJoffreFRousseauHGuermonprezJLLancelinBMoriceMC: Self-expanding coronary endoprosthesis in the prevention of restenosis following transluminal angioplasty. Preliminary clinical study. Arch Mal Coeur Vaiss1987; 80: 1311–1312.
3.
OhmanEMTardiffBE: Periprocedural cardiac marker elevation after percutaneous coronary artery revascularization. Importance and implications. JAMA1997; 277: 495–497.
4.
ShyuKGKuanPLChengJJHungCR: Cardiac troponin T, creatine kinase, and its isoform release after successful percutaneous transluminal coronary angioplasty with or without stenting. Am Heart J1998; 135: 862–867.
5.
SaadeddinSMHabbabMASobkiSHFernsGA: Biochemical detection of minor myocardial injury after elective, uncomplicated, successful percutaneous coronary intervention in patients with stable angina: Clinical outcome. Ann Clin Biochem2002; 39: 392–397.
6.
StubbsP: The cardiac troponins: Uses in routine clinical practice. Experiences from GUSTO and other clinical trials. Review. Eur Heart J1998; 19 Suppl N: N59–N63.
7.
IoannidisJPKarvouniEKatritsisDG: Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous intervention. J Am Coll Cardiol2003; 42: 1406–1411.
8.
CavalliniCSavonittoSVioliniRArraizGPlebaniMOlivariZ: Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: Results of the CK-MB and PCI study. Eur Heart J2005; 26: 1494–1498.
9.
RyanTJBaumanWBKennedyJWKereiakesDJKingSB3rdMcCallisterBD: Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures. J Am Coll Cardiol1993; 22: 2033–2054.
10.
The TIMI study group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med1985; 312: 932–936.
11.
AbdelmeguidAETopolEJWhitlowPLSappSKEllisSG: Significance of mild release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation1996; 94: 1528–1536.
12.
BertinchantJPPolgeALedermannBGenetLFabbro-PerayPRaczkaF: Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris. Am J Cardiol1999; 84: 51–57.
13.
GarbarzELungBLefevreGMakitaYFarahBMichaudP: Frequency and prognostic value of cardiac troponin I elevation after coronary stenting. Am J Cardiol1999; 84: 515–518.
14.
KiniASLeePMarmurJDAgarwalADuffyMEKimMC: Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality. Am J Cardiol2004; 93: 18–23.
15.
CantorWJNewbyLKChristensonRHTuttleRHHasselbladVArmstrongPW: Prognostic significance of elevated troponin I after percutaneous coronary intervention. J Am Coll Cardiol2002; 39: 1738–1744.
16.
KizerJRMuttrejMRMatthaiWHMcConnellJNardoneHSonelAF: Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention. Eur Heart J2003; 24: 1314–1322.
17.
NallamothuBKChetcutiSMukherjeeDGrossmanPMKline-RogersEWernsSW: Prognostic implication of troponin I elevation after percutaneous coronary intervention. Am J Cardiol2003; 91: 1272–1274.
18.
NagehTSherwoodRAHarrisBMByrneJAThomasMR: Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention. Int J Cardiol2003; 92: 285–293.
19.
NatarajanMKKreatsoulasCVelianouJLMehtaSRPericakDGoodhartDM: Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions. Am J Cardiol2004; 93: 750–753.
20.
EzekowitzJAMcAlisterFAArmstrongPW: Anemia is common in heart failure and is associated with poor outcomes: Insights from a cohort of 12,065 patients with new-onset heart failure. Circulation2003; 107: 223–225.
21.
LeePCKiniASAhsanCFisherESharmaSK: Anemia is an independent predictor of mortality after percutaneous coronary intervention. J Am Coll Cardiol2004; 44: 541–546.
22.
McKechnieRSSmithDMontoyeCKline-RogersEO'DonnellMJDeFrancoAC: Prognostic implication of anemia on inhospital outcomes after percutaneous coronary intervention. Circulation2004; 110: 271–277.
23.
CaliffRMAbdelmeguidAKuntzREPopmaJJDavidsonCJCohenEA: Myonecrosis after revascularization procedures. J Am Coll Cardiol1998; 31: 241–251.
24.
MehranRDangasGMintzGSLanskyAJPichardADSatlerLF: Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: Intravascular ultrasound study of 2256 patients. Circulation2000; 101: 604–610.
25.
StoneGWMehranRDangasGLanskyAJKornowskiRLeonMB: Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: A device-specific analysis of 7147 patients. Circulation2001; 104: 642–647.
26.
SaadeddinSMHabbabMASobkiSHFernsGA: Association of systemic inflammatory state with troponin I elevation after elective uncomplicated percutaneous coronary intervention. Am J Cardiol2002; 89: 981–983.
27.
AngeliniARubartelliPMistrorigoFDella BarberaMAbbadessaFVischiM: Distal protection with a filter device during coronary stenting in patients with stable and unstable angina. Circulation2004; 110: 515–521.
28.
WangFWOsmanAOteroJOStoufferGAWaxmanSAfzalA: Distal myocardial protection during percutaneous coronary intervention with an intracoronary beta-blocker. Circulation2003; 107: 2914–2919.
29.
PasceriVPattiGNuscaAlPristipiniCRichichiGDi SciascioG: Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: Results from the ARMYDA study. Circulation2004; 110: 674–678.
30.
DesmetWJDensJCoussementPVan de WerfF: Does adenosine prevent myocardial micronecrosis following percutaneous coronary intervention? The ADELINE pilot trial. Heart2002; 88: 293–295.
31.
BonzAWLengenfelderBStrotmannJHeldSTurschnerOHarreK: Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR Trial). J Am Coll Cardiol2002; 40: 662–668.
